Our Company
Trusted Partner for Quality Solutions.
We are a dedicated commercial biologics CDMO focused on the development and CGMP manufacture of biopharmaceuticals.
Our company has grown and changed over the years - here's our history.
- 1993 Began biologics development and manufacturing as Peregrine Pharmaceuticals
-
2002 Formed Avid Bioservices, Inc. as a wholly owned subsidiary of Peregrine Pharmaceuticals
- 2003 Signed first client for manufacturing services
- 2005 Received first FDA commercial approval
- 2012 Received first EMA commercial approval
- 2016 Commissioned the Myford state-of-the-art commercial manufacturing facility
- 2018 Avid Bioservices Inc. was launched as dedicated, independent biologics manufacturer (NASDAQ:CDMO)
- 2019 Opened the new state-of-the-art process development laboratories
- 2020 Initiation of Phase 1 expansion of Myford Facility
- 2021 Initiation of Phase 2 expansion of Myford Facility
- 2021 Expansion into viral vector development and manufacturing
- 2022 Opened analytical development & process development viral vector suites
- 2023 Commissioning of Myford Drug Substance (DS) Line 3
Our Location
Avid Bioservices is located in Orange County, CA. We currently employ over 350 team members, with approximately 213,000 ft2 of space spanning two campuses. This includes our mammalian protein process development facility, two mammalian protein commercial manufacturing facilities, a cell & gene therapy facility, and our corporate offices.
